Neuroendocrine cell hyperplasia of infancy digital illustration

Neuroendocrine cell hyperplasia of infancy Save


ICD-10 code: J84.841

Disease category: J84.84: Other interstitial lung diseases of childhood

Understanding Neuroendocrine Cell Hyperplasia of Infancy

Neuroendocrine Cell Hyperplasia of Infancy (NEHI) is a rare lung disorder that primarily affects infants. This condition, also known as diffuse neuroendocrine cell hyperplasia, is characterized by an abnormal increase in neuroendocrine cells in the lungs. NEHI can cause respiratory symptoms such as chronic cough, rapid breathing, and difficulty in gaining weight.

While the exact cause of NEHI is unknown, it is believed to be a congenital condition. It is not inherited and does not have any known risk factors. NEHI affects both boys and girls equally and is typically diagnosed during the first year of life.

One of the key features of NEHI is the excessive growth of neuroendocrine cells in the lungs. These cells are responsible for producing hormones and regulating various bodily functions. In NEHI, the increased number of neuroendocrine cells can lead to the narrowing of the airways, making it difficult for the child to breathe properly.

Diagnosing NEHI requires a thorough evaluation of the child's medical history, physical examination, and additional tests. These tests may include lung function tests, chest X-rays, and high-resolution computed tomography (HRCT) scans. A lung biopsy may also be performed to confirm the diagnosis.

Although there is no specific treatment for NEHI, the condition usually improves over time. Many children with NEHI experience spontaneous resolution of symptoms by the age of 2 to 3 years. Therefore, healthcare providers often focus on managing the symptoms and providing supportive care.

  1. Monitoring the child's growth and development is crucial to ensure appropriate interventions are implemented if needed.
  2. Providing oxygen therapy can help alleviate breathing difficulties and improve oxygen levels in the blood.
  3. Encouraging a healthy lifestyle, including a well-balanced diet and regular exercise, can support overall lung health.
  4. Reducing exposure to respiratory irritants such as tobacco smoke and air pollution can help prevent exacerbation of symptoms.
  5. Regular follow-up visits with healthcare providers are essential to monitor the child's progress and adjust the management plan accordingly.

Neuroendocrine Cell Hyperplasia of Infancy is a challenging condition for infants and their families. While it can cause significant respiratory symptoms, the prognosis is generally favorable. With proper care and monitoring, most children with NEHI can lead healthy lives as they grow older.

Treatment of Neuroendocrine cell hyperplasia of infancy:

Treatment Options for Neuroendocrine Cell Hyperplasia of Infancy

Neuroendocrine cell hyperplasia of infancy (NEHI) is a rare lung disease that primarily affects infants. It is characterized by an overgrowth of neuroendocrine cells in the lungs, leading to breathing difficulties. While NEHI is a chronic condition with no specific cure, there are several treatment options available to...

To see full information about treatment please Sign up or Log in